Severe Anion Gap Metabolic Acidosis From Acetaminophen Use Secondary to 5-Oxoproline (Pyroglutamic Acid) Accumulation
Authors:
- Angela MuriithiAMAngela Muriithi
- Eddie L. GreeneEGEddie L. Greene
- Qi QianQQQi Qian
- Ziad M. El-ZoghbyZEZiad M. El-Zoghby
- Pablo M. FrancoPFPablo M. Franco
- Eric NelsenENEric Nelsen
- 1 December 2012
- journal article
- case report
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 344 (6) , 501-504
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Current issues with acetaminophen hepatotoxicity—A clinically relevant model to test the efficacy of natural productsLife Sciences, 2011
- Increased Anion Gap Metabolic Acidosis as a Result of 5-Oxoproline (Pyroglutamic Acid)Clinical Journal of the American Society of Nephrology, 2006
- Acetaminophen-Induced Anion Gap Metabolic Acidosis and 5-Oxoprolinuria (Pyroglutamic Aciduria) Acquired in HospitalAmerican Journal of Kidney Diseases, 2005
- Clinical acid–base pathophysiology: disorders of plasma anion gapBest Practice & Research Clinical Endocrinology & Metabolism, 2003
- Anion Gap Acidosis Associated with AcetaminophenAnnals of Internal Medicine, 2000
- Pyroglutamic acidemia: A cause of high anion gap metabolic acidosisCritical Care Medicine, 2000
- 5-Oxoprolinuria in patients with and without defects in the -glutamyl cycleEuropean Journal of Pediatrics, 1999
- Plasma glutathione level in paracetamol daily abuser patients. Changes in plasma cysteine and thiol groups after reduced glutathione administrationToxicology Letters, 1992
- The excretion of 5‐oxoproline in urine, as an index of glycine status, during normal pregnancyBJOG: An International Journal of Obstetrics & Gynaecology, 1989
- Biochemical heterogeneity in glutathione synthetase deficiency.Journal of Clinical Investigation, 1978